Neurovascular Regulation During Exercise in Humans With Chronic Kidney Disease: Sympatholysis in CKD - Trial NCT05928936
Access comprehensive clinical trial information for NCT05928936 through Pure Global AI's free database. This Phase 2 trial is sponsored by Emory University and is currently Recruiting. The study focuses on Chronic Kidney Disease. Target enrollment is 156 participants.
This page provides complete trial specifications, intervention details, outcomes, and location information. Pure Global AI offers free access to ClinicalTrials.gov data, helping medical device and pharmaceutical companies navigate clinical research efficiently.
Study Focus
Sponsor & Location
Emory University
Timeline & Enrollment
Phase 2
Nov 11, 2022
Jun 01, 2028
Primary Outcome
Change in Exercise Capacity
Summary
The goals of this project are to investigate the mechanisms and potential therapies related
 to exercise capacity in persons with chronic kidney disease (CKD).
ICD-10 Classifications
Data Source
ClinicalTrials.gov
NCT05928936
Non-Device Trial